Table 1 |
|||
|
Genetic engineering strategies which have been applied to the enhancement of recombinant protein production in bacteria |
|||
|
Method |
Strain |
Target protein |
Reference |
|
|
|||
|
Spontaneous chromosomal mutagenesis |
C(1(DE3), C43(DE3) |
Bovine OGCP; bovine phosphate carrier; bovine ADP/ATP translocase; Bacillus subtilis PS3 alanine/H+ carrier; E. coli F-ATPase subunits b and c; bovine F-ATPase subunits b, d, α, β, γ, δ, OSCP, F6; bovine F-ATPase inhibitor protein; Aequoria victoria GFP |
[58] |
|
|
|||
|
Chromosomal mutagenesis using chemical mutagens or mutator genes |
EXP-Rv1337-1, EXP-Rv1337-2, EXP-Rv1337-3, EXP-Rv1337-4, EXP-Rv1337-5 |
Mycobacterium tuberculosis Rv1337, M. tuberculosis Rv2746, M. tuberculosis Rv2835, M. tuberculosis Rv0110, Methanocccus jannaschii rhomboid (MJR), Drosophila melanogaster rhomboid 1 (Rho1) |
[60] |
|
|
|||
|
GS1, TM1, TM2, TM3, TM4, TM5, TM6 |
Variants of human IgG1 |
[61] |
|
|
|
|||
|
Transposon mutagenesis |
GS101 (MC4100A dnaJ349::Tn5 (KanR)) GS102 (MC4100A dinG1377::Tn5 (KanR)) GS103 (MC4100A nhaR63::Tn5 (KanR)) GS104 (MC4100A ΔdinG) GS105 (MC4100A ΔdinG dnaJ349::Tn5 (KanR)) |
Human central cannabinoid receptor (CB1) |
[62] |
|
|
|||
|
Co-expression of the ASKA library |
MC4100A (+ybaB) MC4100A (+yciQ) MC4100A (+glpQ)* |
Human bradykinin receptor 2 (BR2), CB1, human neurokinin (substance P) receptor 1 (NKR1), E. coli YidC, E. coli CstA, human stearoyl-CoA desaturase (SCD) |
[64] |
|
|
|||
|
*MC 100A (+name of gene) denotes an MC 100 strain overexpressing the E. coli gene specified in parentheses. |
|||
|
Makino et al. Microbial Cell Factories 2011 10:32 doi:10.1186/1475-2859-10-32 |
|||